Abstracts by keywords: drug supply
Effect of discount contract tenders
The introduction of individual contracts in the area of pharmaceuticals enabled the statutory health insurance companies to carry out further structural development, so that the significant savings potential, particularly in the generics market, could be leveraged. Since 2003, health insurance companies have had the option of concluding discount agreements with drug manufacturers. With the legal changes to the GKV-WSG, these contracts have been able to take effect since 2007, since since then pharmacists have also been obliged to sell discounted products unless the prescribing doctor has ruled out substitution.